Quantcast

Latest Shinya Yamanaka Stories

2011-03-16 08:30:00

ALBANY, N.Y., March 16, 2011 /PRNewswire-USNewswire/ -- Three scientists whose pioneering work in isolating human stem cells holds great promise for the future of medicine have been named the recipients of the 11th annual Albany Medical Center Prize in Medicine and Biomedical Research. They are: Elaine Fuchs, Ph.D., the Rebecca C. Lancefield Professor, head of the Laboratory of Mammalian Cell Biology and Development, and a Howard Hughes Medical Institute investigator at The Rockefeller...

2010-10-25 01:00:00

PARIS and KYOTO, Japan, Oct. 25 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and the Center for iPS Cells Research and Application (CiRA) of Kyoto University, Kyoto, Japan, have announced today that they have started a scientific collaboration to combine Cellectis' genome engineering technologies with CiRA's induced pluripotent stem cell (iPS) technology to improve the natural characteristics of iPS cells for use as cellular tools. CiRA was...

2010-10-18 01:00:00

PARIS and KYOTO, Japan, Oct. 18 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent Stem (iPS) cells patent portfolio arising from the work of Professor Shinya Yamanaka, MD, Ph.D., Center for iPS Cell Research and Application (CiRA) at the University of Kyoto, Japan. The...

2010-08-05 16:33:21

Next-generation reprogramming of native cells offers therapeutic advantages Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have found a new way to make beating heart cells from the body's own cells that could help regenerate damaged hearts. Over 5 million Americans suffer from heart failure because the heart has virtually no ability to repair itself after a heart attack. Only 2,000 hearts become available for heart transplant annually in the United States, leaving...

2010-07-01 13:58:00

Patients can provide cells for reprogramming during routine blood draws BOSTON, July 1 /PRNewswire-USNewswire/ -- In findings likely to make it easier and faster for stem cell biologists to generate patient-specific embryonic-like stem cells, researchers at Children's Hospital Boston have reprogrammed adult blood cells into induced pluripotent stem (iPS) cells. This advance will further enable scientists to model a patient's disease in a laboratory dish and potentially create healthy...

2010-05-07 01:00:00

MADISON, Wis., May 7 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University. CDI is the first company...

2010-01-28 07:00:00

SOUTH SAN FRANCISCO, Calif., Jan. 28 /PRNewswire/ -- iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced that the Intellectual Property Office in the United Kingdom has issued a Notification of Grant to iPierian for UK patent No. GB2450603, its first patent related to induced pluripotent stem cell (iPSC) technology. The newly granted UK patent covers the...

2010-01-26 12:00:00

New Method Bypasses Need to Obtain Stem Cells From Embryos WHITE PLAINS, N.Y., Jan. 26 /PRNewswire-USNewswire/ -- The scientist who reprogrammed adult cells into embryonic-like stem cells has been chosen to receive the 2010 March of Dimes Prize in Developmental Biology. Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease, San Francisco, and Kyoto University, Japan, will be honored with the 2010 March of Dimes Prize for his pioneering work that has fundamentally...

56d53062dba23e277b81fe4d2f5fedf61
2009-09-14 12:46:10

Several prestigious research awards were handed out to five scientists for developing a life-saving leukemia treatment and for advances in "reprogramming" DNA, which led to a new kind of stem cell, The Associated Press reported. The Albert and Mary Lasker Foundation will present the $250,000 Lasker Awards on Oct. 2 in New York. New York mayor Michael Bloomberg will also be receiving a Lasker prize for public service. This year, three scientists will share the clinical medical research award...

2009-09-01 07:30:00

SOUTH SAN FRANCISCO, Calif., Sept. 1 /PRNewswire/ -- iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced the appointment of Matthew J. Plunkett, Ph.D., as vice president and chief financial officer. "Capital formation is critical to our long term success, and Matt's career over the last decade has given him the experience and network to help position iPierian with...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.